Immunobiologic differences between normal and leukemic human B-cell precursors.
about
Membrane-associated CD19-LYN complex is an endogenous p53-independent and Bc1-2-independent regulator of apoptosis in human B-lineage lymphoma cellsAnti-human immunodeficiency virus type 1 activity of an anti-CD4 immunoconjugate containing pokeweed antiviral proteinDifferentiation of naive cord-blood T cells into CD19-specific cytolytic effectors for posttransplantation adoptive immunotherapy.The CD19 signal transduction molecule is a response regulator of B-lymphocyte differentiation.Di-, tri- and tetrameric single chain Fv antibody fragments against human CD19: effect of valency on cell binding.Intrinsic radiation resistance of primary clonogenic blasts from children with newly diagnosed B-cell precursor acute lymphoblastic leukemia.Detection and characterization of human high molecular weight B cell growth factor receptors on leukemic B cells in chronic lymphocytic leukemia.Immunoglobulin recombinase gene activity is modulated reciprocally by interleukin 7 and CD19 in B cell progenitors.Tissue-specific expression of the human CD19 gene in transgenic mice inhibits antigen-independent B-lymphocyte development.Fetal liver pro-B and pre-B lymphocyte clones: expression of lymphoid-specific genes, surface markers, growth requirements, colonization of the bone marrow, and generation of B lymphocytes in vivo and in vitro.Flowcytometric comparative analysis in acute leukemias between Indian and proposed minimal screening panel.Ionizing radiation stimulates unidentified tyrosine-specific protein kinases in human B-lymphocyte precursors, triggering apoptosis and clonogenic cell deathA human non-XLA immunodeficiency disease characterized by blockage of B cell development at an early proB cell stage.Interleukin 7 receptor ligation stimulates tyrosine phosphorylation, inositol phospholipid turnover, and clonal proliferation of human B-cell precursors.Interleukin 7 receptor engagement stimulates tyrosine phosphorylation, inositol phospholipid turnover, proliferation, and selective differentiation to the CD4 lineage by human fetal thymocytes.Hematogones: a review and update.Performance of CD3xCD19 bispecific monoclonal antibodies in B cell malignancy.Prognostic significance of the CD10+CD19+CD34+ B-progenitor immunophenotype in children with acute lymphoblastic leukemia: a report from the Children's Cancer Group.Inducing apoptosis in chemotherapy-resistant B-lineage acute lymphoblastic leukaemia cells by targeting HSPA5, a master regulator of the anti-apoptotic unfolded protein response signalling network.Bispecific CD3 x CD19 diabody for T cell-mediated lysis of malignant human B cells.Distinct in vivo engraftment and growth patterns of t(1;19)+/E2A-PBX1+ and t(9;22)+/BCR-ABL+ human leukemia cells in SCID mice.Histamine as an autocrine regulator of leukemic cell proliferation.Primary blasts from infants with acute lymphoblastic leukemia cause overt leukemia in SCID mice.Sensitivity of primary clonogenic blasts from acute lymphoblastic leukemia patients to an activated cyclophosphamide, viz., mafosfamide.
P2860
Q24563175-FC0E2C51-632B-40E9-A1F1-95EDEF536B7EQ28378710-14B4BF2F-244C-45B9-8791-02483BFB69EAQ30479628-D5FB54FA-2D92-4148-B758-D860182BEC9EQ33707690-178A7512-4BFE-441B-85C6-419362D6E976Q33867792-260A88AF-8E0E-4C2D-A406-6CD0B02FD48EQ33893516-C435830F-DE42-4A58-9232-7A06043A0E0CQ34579417-3A0C7473-788F-44E5-B179-483BECD1BB67Q36365782-C51BC5BD-542E-46B3-9435-A3FE6F13B206Q36654682-13FFC8E6-7CE8-4AEA-B8F6-9A28EB137F62Q36811855-98CD1AAE-767B-4B98-BBD9-6BB02927EDEAQ37171303-C05377F2-662C-4F29-9E19-FA5DA660C668Q37218100-5AF01765-E645-4424-8DD2-BDCB459F709EQ37360170-198092CA-2F24-4B81-9C4C-40F194B6E3DDQ37492618-48338095-432F-4D7A-9F54-D1DE3A7928ACQ37552011-F28300D4-943D-4CE2-93CB-84743D3E0109Q37650207-F38170E6-79B0-48A6-946E-6691915CBC0FQ40963463-41598BE2-5AAA-4A2C-BA33-4AD998CA8DE6Q43572378-F1E97940-6DE3-43AD-8F2F-5A9BAA31E1E7Q46134516-EF5218EC-07BB-46DC-BEFD-96F2308D7DBAQ47751085-E8837BD7-53E9-4289-8E41-D04A60C54971Q48276056-01B1AE1B-6638-4D83-A9BB-8F3ABFA42625Q51418069-61D03B70-6617-433A-AADD-87B3D71CAC75Q54127314-8EE81E0B-E77A-4737-AA2D-1832636D9767Q54206869-E12F6226-332F-4899-9212-203AD829BDDE
P2860
Immunobiologic differences between normal and leukemic human B-cell precursors.
description
1988 nî lūn-bûn
@nan
1988 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Immunobiologic differences between normal and leukemic human B-cell precursors.
@ast
Immunobiologic differences between normal and leukemic human B-cell precursors.
@en
type
label
Immunobiologic differences between normal and leukemic human B-cell precursors.
@ast
Immunobiologic differences between normal and leukemic human B-cell precursors.
@en
prefLabel
Immunobiologic differences between normal and leukemic human B-cell precursors.
@ast
Immunobiologic differences between normal and leukemic human B-cell precursors.
@en
P2860
P356
P1476
Immunobiologic differences between normal and leukemic human B-cell precursors.
@en
P2093
J A Ledbetter
P2860
P304
P356
10.1073/PNAS.85.22.8603
P407
P577
1988-11-01T00:00:00Z